Trials / Terminated
TerminatedNCT03020368
Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint
Effectiveness and Safety of Breeded Leech "Medileech" by BioRepro GmbH for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint: a Randomized Controlled Clinical Trial
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 35 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
In this trial the investigators want to prove the efficacy and safety of a one-time topical leech application at patients with symptomatic primary arthrosis of the first carpometacarpal joint in comparison to the standard therapy with topical diclofenac.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Leeches | |
| DRUG | Diclofenac |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2017-01-13
- Last updated
- 2019-02-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03020368. Inclusion in this directory is not an endorsement.